These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 2580580)

  • 21. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
    Zehender H; Witte EC; Wolff HP; Patscheke H
    Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.
    Jones RL; Peesapati V; Wilson NH
    Br J Pharmacol; 1982 Jul; 76(3):423-38. PubMed ID: 6286023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
    Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
    Mais DE; Liel N; Halushka PV
    Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S; Whittle BJ
    Br J Pharmacol; 1986 Aug; 88(4):931-6. PubMed ID: 3017497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets.
    Halushka PV; Kochel PJ; Mais DE
    Br J Pharmacol; 1987 May; 91(1):223-7. PubMed ID: 3594077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
    Parent CA; Lagarde M; Venton DL; Le Breton GC
    J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes.
    Halushka PV; Boehm A; Mais DE
    Eicosanoids; 1988; 1(1):41-4. PubMed ID: 2856171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
    Turini ME; Holub BJ
    Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
    Theis JG; Dellweg H; Perzborn E; Gross R
    Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.
    Saussy DL; Mais DE; Knapp DR; Halushka PV
    Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).
    Kattelman EJ; Venton DL; Le Breton GC
    Thromb Res; 1986 Feb; 41(4):471-81. PubMed ID: 3008368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L; Fitzgerald DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.